Question 1

How many shares of AGL does D. E. Shaw & Co., Inc. own?

Accepted Answer

As of 2026-Q2, D. E. Shaw & Co., Inc. holds 390,149 shares of AGL (AGILON HEALTH INC).

Question 2

What is D. E. Shaw & Co., Inc.'s AGL position worth?

Accepted Answer

As of 2026-Q2, D. E. Shaw & Co., Inc.'s AGL position is worth $41.8M.

Question 3

Is D. E. Shaw & Co., Inc. buying or selling AGL?

Accepted Answer

In 2026-Q2, D. E. Shaw & Co., Inc. decreased their AGL position (-47.4% change in shares).

Question 4

When did D. E. Shaw & Co., Inc. first buy AGL?

Accepted Answer

Based on available 13F filings, D. E. Shaw & Co., Inc. first reported a position in AGL in 2024-Q3. They have held the position across 15 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	390,149	-47.4%	$41.8M	0.0%	$107.18	0
2026-Q1	Decreased	742,218	-96.3%	$5.9M	0.0%	$0.57	0
2025-Q4	Increased	20.3M	+103.2%	$14M	0.0%	$0.71	45
2025-Q3	Increased	10M	+600.9%	$10.3M	0.0%	$1.11	45
2025-Q2	Increased	1.4M	+44.2%	$3.3M	0.0%	$2.31	36
2025-Q1	Increased	988,607	+167.7%	$4.3M	0.0%	$4.49	43
2024-Q4	Increased	369,286	+0.6%	$701,643	0.0%	$1.91	25
2024-Q3	Increased	367,270	+102.4%	$1.4M	0.0%	$3.74	41